首页 > 市场调查报告书 > 材料/化学品

化学品

市场调查报告书

商品编码

1777426

全球亚磷酰胺市场

Phosphoramidite

出版日期: 2025年07月28日 | 出版商:

Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球亚磷酰胺市场规模将达到 16 亿美元

全球亚磷酰胺市场规模预计在2024年为11亿美元，到2030年将达到16亿美元，在2024-2030年的分析期间内，复合年增长率为6.3%。 DNA亚磷酰胺是本报告分析的细分市场之一，预计其复合年增长率为7.4%，到分析期结束时市场规模将达到6.627亿美元。 RNA亚磷酰胺细分市场在分析期间的复合年增长率预计为4.4%。

美国市场规模估计为 3.065 亿美元，中国市场预计复合年增长率为 10.1%

美国亚磷酰胺市场规模预计在2024年达到3.065亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到3.36亿美元，在分析期间（2024-2030年）的复合年增长率为10.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.0%和6.2%。在欧洲，德国的复合年增长率预计为4.1%。

亚磷酰胺市场：主要趋势和驱动因素摘要

为什么亚磷酰胺是核酸合成的重要组成部分？

亚磷酰胺化学在DNA、RNA和寡核苷酸的合成中起着基础性作用，使其成为分子生物学、药物研究和基因工程中的重要试剂。亚磷酰胺是用于固相合成的活性中间体，固相合成是一种广泛用于生产用于PCR、基因编辑、反义疗法、siRNA（小干扰RNA）和基于CRISPR的基因编辑技术的合成寡核苷酸的方法。

合成生物学、基因治疗和个人化医疗的日益普及，推动了对高纯度亚磷酰胺的需求激增。製药公司、生物技术公司和学术研究机构依靠亚磷酰胺化学来製造诊断检测、疫苗开发和标靶药物递送系统所必需的客製化DNA和RNA序列。此外，次世代定序(NGS)和RNA疗法正在拓展亚磷酰胺的应用范围，进一步推动市场成长。

推动亚磷酰胺市场发展的关键趋势是什么？

受基因医学、合成生物学和核酸疗法的推动，亚磷酰胺市场正在快速扩张。一些关键趋势正在塑造该行业的成长轨迹。

最重要的趋势之一是对核酸疗法的需求不断增长，尤其是mRNA疫苗、反义寡核苷酸(ASO)和小干扰RNA(siRNA)疗法。基于mRNA的COVID-19疫苗的成功证明了合成RNA的潜力，并刺激了对用于大规模RNA生产的修饰和未修饰亚磷酰胺的需求。随着基于mRNA的癌症免疫疗法、个人化疫苗和罕见疾病治疗的发展势头强劲，亚磷酰胺製造商正在扩大产能，以满足行业日益增长的需求。

另一个重要趋势是 CRISPR 和基因编辑技术的兴起。基于 CRISPR 的系统依赖于利用亚磷酰胺化学方法合成的合成嚮导 RNA (gRNA) 分子。基因编辑研究、细胞和基因治疗应用以及精准医疗的扩展，推动了对用于治疗应用的高纯度特种亚磷酰胺的需求。

次世代定序(NGS) 和分子诊断也是亚磷酰胺消费的主要驱动力。 NGS 平台使用合成寡核苷酸作为定序引子和接头，因此需要大规模生产稳定性和更有效率的改质亚磷酰胺。随着液态切片诊断、个人化基因组学和病原体检测方法的日益普及，基于亚磷酰胺的试剂在临床和研究领域中变得至关重要。

此外，化学修饰和专用亚磷酰胺正在拓展其应用可能性。萤光标记亚磷酰胺、生物共轭衍生物和锁核酸 (LNA) 亚磷酰胺正在协助开发先进的分子探针、即时PCR检测和基于 RNA 的疗法。用于高通量筛检(HTS)、药物研发和奈米颗粒药物递送系统的亚磷酰胺试剂客製化正在进一步推动市场创新。

最终用途应用如何影响亚磷酰胺市场？

亚磷酰胺的应用范围广泛，涵盖製药、生物技术、分子诊断和合成生物学等多个产业。每个领域都有其独特的需求，这影响着专用亚磷酰胺试剂的开发和生产。

製药和生物技术产业是亚磷酰胺的最大消费者，尤其是在基于寡核苷酸的药物开发领域。开发反义寡核苷酸 (ASO)、siRNA 药物、基于适体的疗法和 mRNA 疫苗的公司利用亚磷酰胺化学进行精准寡核苷酸合成。 FDA核准了几种基于 RNA 的疗法，例如 patisiran（遗传性 ATTR类淀粉沉积症）和 nusinersen（脊髓性肌肉萎缩症），这加速了对基于亚磷酰胺的药物开发的投资。

在分子诊断和基因组学领域，基于亚磷酰胺的寡核苷酸已成为PCR引子、定序探针、微阵列和基因表现分析的重要组成部分。随着照护现场诊断、传染病筛检和癌症生物标记检测的兴起，对高保真修饰核苷酸的需求日益增长。随着液态切片技术和家用基因检测套组成为主流，亚磷酰胺供应商正在扩展其产品线，以满足各种应用的需求。

合成生物学领域是亚磷酰胺的另一个快速成长的市场。科学家正在设计客製化的DNA和RNA序列，以创建用于工业和环境应用的基因改造生物（GMO）、生物技术酶以及合成代谢途径。基于亚磷酰胺的DNA合成与农业生物技术、生质燃料生产和酵素工程的整合，为市场带来了新的成长机会。

哪些因素推动了亚磷酰胺市场的成长？

亚磷酰胺市场的成长受到多种因素的推动，包括基因医学的进步、核酸药物的核准增加以及合成生物学应用的扩大。

关键成长要素之一是对基于RNA的疗法和疫苗的需求不断增长。 mRNA疫苗平台的成功证明了RNA是一种可行的治疗工具，这鼓励製药公司投资RNA干扰(RNAi)疗法、自扩增RNA(saRNA)疫苗和环状RNA(circRNA)技术。这导致针对RNA合成、化学修饰和奈米颗粒製备的亚磷酰胺试剂需求增加。

自动化DNA/RNA合成仪的技术进步也推动了市场的成长。高通量寡核苷酸合成仪的引入提高了客製化核酸製造的效率，使研究人员能够产生更长、更复杂、且精确修饰的RNA分子。亚磷酰胺製造商正致力于提高试剂的纯度、稳定性和储存性能，以支援高通量合成应用。

此外，核酸药物监管核准的不断增加也增强了市场需求。 FDA 和 EMA 等监管机构已核准了多种反义寡核苷酸、siRNA 药物和基因编辑疗法，增强了寡核苷酸药物的商业性潜力。随着越来越多的公司进入 RNA 疗法和基因治疗领域，对高品质亚磷酰胺试剂的需求预计将激增。

永续性和绿色化学措施也对亚磷酰胺的生产产生了影响。无溶剂和酵素DNA合成技术正成为传统亚磷酰胺化学合成的环保替代方案。虽然这些技术仍处于早期阶段，但各公司正在投资更永续的试剂配方和更环保的合成方法，以符合全行业的环保目标。

部分

类型（DNA亚磷酰胺、RNA亚磷酰胺、标记亚磷酰胺、改质亚磷酰胺等）、用途（药物发现和开发、诊断开发等）、最终用途（製药和生物技术公司、学术和研究机构等）

受访公司范例

ATDBio Ltd.
BioAutomation Corporation
BIONEER Corporation
Bio-Synthesis Inc.
ChemGenes Corporation
Expedeon AG
Genscript Biotech Corporation
Hongene Biotech Corporation
Honya Biotech
Integrated DNA Technologies, Inc.
LGC Biosearch Technologies
Link Technologies Ltd.
Lumiprobe Corporation
Merck KGaA
PolyOrg, Inc.
QIAGEN NV
Sigma-Aldrich（MilliporeSigma）
Thermo Fisher Scientific Inc.
TriLink BioTechnologies
Wuxi Donglin Sci & Tech Dev. Co.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for Phosphoramidite estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. DNA Phosphoramidites, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$662.7 Million by the end of the analysis period. Growth in the RNA Phosphoramidites segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.5 Million While China is Forecast to Grow at 10.1% CAGR

The Phosphoramidite market in the U.S. is estimated at US$306.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$336.0 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Phosphoramidite Market: Key Trends & Drivers Summarized

Why Is Phosphoramidite a Crucial Component in Nucleic Acid Synthesis?

Phosphoramidite chemistry plays a fundamental role in the synthesis of DNA, RNA, and oligonucleotides, making it a critical reagent in molecular biology, pharmaceutical research, and genetic engineering. Phosphoramidites are reactive intermediates used in solid-phase synthesis, a method widely employed in the production of synthetic oligonucleotides for PCR, gene editing, antisense therapies, siRNA (small interfering RNA), and CRISPR-based gene editing technologies.

As synthetic biology, gene therapies, and personalized medicine gain traction, demand for high-purity phosphoramidites has surged. Pharmaceutical companies, biotech firms, and academic research institutions rely on phosphoramidite chemistry to produce custom DNA and RNA sequences, which are essential for diagnostic assays, vaccine development, and targeted drug delivery systems. Additionally, next-generation sequencing (NGS) and RNA therapeutics have expanded the application scope of phosphoramidites, further driving market growth.

What Are the Key Trends Driving the Phosphoramidite Market?

The phosphoramidite market is undergoing rapid expansion, fueled by advancements in genetic medicine, synthetic biology, and nucleic acid-based therapeutics. Several key trends are shaping the industry's growth trajectory.

One of the most significant trends is the increasing demand for nucleic acid-based therapeutics, particularly mRNA vaccines, antisense oligonucleotides (ASOs), and small interfering RNA (siRNA) therapies. The success of mRNA-based COVID-19 vaccines has demonstrated the potential of synthetic RNA, boosting demand for modified and unmodified phosphoramidites used in large-scale RNA production. As mRNA-based cancer immunotherapies, personalized vaccines, and rare disease treatments gain momentum, phosphoramidite manufacturers are scaling up production capacity to meet growing industry needs.

Another important trend is the rise of CRISPR and gene editing technologies. CRISPR-based systems rely on synthetic guide RNA (gRNA) molecules, which are synthesized using phosphoramidite chemistry. The expansion of gene editing research, cell and gene therapy applications, and precision medicine is driving demand for high-purity, specialty phosphoramidites designed for therapeutic applications.

The next-generation sequencing (NGS) and molecular diagnostics sectors are also key drivers of phosphoramidite consumption. NGS platforms use synthetic oligonucleotides as sequencing primers and adapters, necessitating the large-scale production of modified phosphoramidites with enhanced stability and efficiency. With the growing adoption of liquid biopsy diagnostics, personalized genomics, and pathogen detection assays, phosphoramidite-based reagents are becoming indispensable in clinical and research settings.

Additionally, chemical modifications and specialty phosphoramidites are expanding application possibilities. Fluorescent-labeled phosphoramidites, bioconjugated derivatives, and locked nucleic acid (LNA) phosphoramidites are enabling the development of advanced molecular probes, real-time PCR assays, and RNA-based therapeutics. The customization of phosphoramidite reagents for high-throughput screening (HTS), drug discovery, and nanoparticle-based drug delivery systems is further driving market innovation.

How Are End-Use Applications Influencing the Phosphoramidite Market?

The diverse applications of phosphoramidites span multiple industries, including pharmaceuticals, biotechnology, molecular diagnostics, and synthetic biology. Each sector presents unique requirements, influencing the development and production of specialized phosphoramidite reagents.

The pharmaceutical and biotech industries represent the largest consumers of phosphoramidites, particularly for oligonucleotide-based drug development. Companies developing antisense oligonucleotides (ASOs), siRNA drugs, aptamer-based therapeutics, and mRNA vaccines rely on phosphoramidite chemistry for precise oligonucleotide synthesis. The FDA’s approval of multiple RNA-based therapies, such as patisiran (for hereditary ATTR amyloidosis) and nusinersen (for spinal muscular atrophy), has accelerated investments in phosphoramidite-based drug development.

In molecular diagnostics and genomics, phosphoramidite-based oligonucleotides are essential components of PCR primers, sequencing probes, microarrays, and gene expression assays. The demand for high-fidelity, modified nucleotides has increased with the rise of point-of-care diagnostics, infectious disease screening, and cancer biomarker detection. As liquid biopsy technologies and at-home genetic testing kits become mainstream, phosphoramidite suppliers are expanding their offerings to meet diverse application needs.

The synthetic biology sector is another rapidly growing market for phosphoramidites. Scientists are engineering custom DNA and RNA sequences to create genetically modified organisms (GMOs), bioengineered enzymes, and synthetic metabolic pathways for industrial and environmental applications. The integration of phosphoramidite-based DNA synthesis into agricultural biotechnology, biofuel production, and enzyme engineering is opening new growth opportunities for the market.

What Factors Are Driving the Growth of the Phosphoramidite Market?

The growth in the phosphoramidite market is driven by multiple factors, including advancements in genetic medicine, increasing nucleic acid-based drug approvals, and the expansion of synthetic biology applications.

One of the primary growth drivers is the rising demand for RNA-based therapeutics and vaccines. The success of mRNA vaccine platforms has validated RNA as a viable therapeutic modality, encouraging pharmaceutical companies to invest in RNA interference (RNAi) therapies, self-amplifying RNA (saRNA) vaccines, and circular RNA (circRNA) technologies. This has led to increased demand for phosphoramidite reagents tailored for RNA synthesis, chemical modifications, and nanoparticle formulation.

Technological advancements in automated DNA/RNA synthesizers are also propelling market growth. The introduction of high-throughput oligonucleotide synthesizers has improved the efficiency of custom nucleic acid production, enabling researchers to generate longer, more complex RNA molecules with precise modifications. Manufacturers of phosphoramidites are focusing on improving reagent purity, stability, and shelf life to support high-throughput synthesis applications.

Additionally, the expanding regulatory approval of nucleic acid-based drugs is strengthening market demand. Regulatory agencies such as the FDA and EMA have approved multiple antisense oligonucleotides, siRNA-based drugs, and gene-editing therapies, reinforcing the commercial viability of oligonucleotide-based pharmaceuticals. As more companies enter the RNA therapeutics and gene therapy space, the demand for high-quality phosphoramidite reagents is expected to surge.

Sustainability and green chemistry initiatives are also influencing phosphoramidite production. Solvent-free and enzymatic DNA synthesis technologies are emerging as eco-friendly alternatives to traditional phosphoramidite-based chemical synthesis. While these technologies are still in their early stages, companies are investing in more sustainable reagent formulations and greener synthesis methods to align with industry-wide environmental goals.

SCOPE OF STUDY:

The report analyzes the Phosphoramidite market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Others); Application (Drug Discovery & Development, Diagnostics Development, Others); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

ATDBio Ltd.
BioAutomation Corporation
BIONEER Corporation
Bio-Synthesis Inc.
ChemGenes Corporation
Expedeon AG
Genscript Biotech Corporation
Hongene Biotech Corporation
Honya Biotech
Integrated DNA Technologies, Inc.
LGC Biosearch Technologies
Link Technologies Ltd.
Lumiprobe Corporation
Merck KGaA
PolyOrg, Inc.
QIAGEN N.V.
Sigma-Aldrich (MilliporeSigma)
Thermo Fisher Scientific Inc.
TriLink BioTechnologies
Wuxi Donglin Sci & Tech Dev. Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Phosphoramidite - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Demand for Oligonucleotide Therapeutics and mRNA Technologies Spurs Use of High-Purity Phosphoramidites
- Expansion of Nucleic Acid-Based Drug Development Strengthens Business Case for Custom and Modified Phosphoramidites
- Growth in Gene Editing and CRISPR Applications Drives Need for High-Fidelity Phosphoramidite Synthesis
- Increased Use of DNA and RNA Probes in Diagnostics and Research Fuels Market for Functionalized Phosphoramidites
- Commercialization of RNA Vaccines and Antisense Therapies Accelerates Demand for Large-Scale Phosphoramidite Manufacturing
- Advancements in Solid-Phase Oligonucleotide Synthesis Technology Enhance Efficiency and Yield of Phosphoramidite Reagents
- Emergence of Synthetic Biology and DNA Data Storage Expands Use Cases for Specialty Phosphoramidites
- Growing Investment in Personalized Medicine and Targeted Therapies Supports Custom Nucleotide Synthesis Markets
- Automation and Miniaturization in Oligo Synthesis Platforms Propel Demand for High-Throughput Phosphoramidite Reagents
- Rising R&D in Aptamers, siRNA, and miRNA-Based Therapeutics Generates Demand for Modified Nucleotide Building Blocks
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Phosphoramidite Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Phosphoramidite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for DNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for DNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for DNA Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for RNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for RNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for RNA Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Labeled Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Labeled Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Labeled Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Modifier Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Modifier Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Modifier Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Diagnostics Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Diagnostics Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Diagnostics Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 38: USA Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
JAPAN
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 56: Japan Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Japan 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
CHINA
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 65: China Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: China 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
EUROPE
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 74: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Phosphoramidite by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: Europe 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
FRANCE
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 86: France Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: France 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: France 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
GERMANY
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 95: Germany Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Germany 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Germany 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
ITALY
- TABLE 104: Italy Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: Italy 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: Italy 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 113: UK Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: UK 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: UK 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
SPAIN
- TABLE 122: Spain Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Spain 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Spain 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Spain 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 131: Russia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Russia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Russia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Russia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of Europe 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Rest of Europe 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Rest of Europe 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Phosphoramidite by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
AUSTRALIA
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 161: Australia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Australia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: Australia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: Australia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
INDIA
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 170: India Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: India 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: India 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: India 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: South Korea 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: South Korea 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: South Korea 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
LATIN AMERICA
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Phosphoramidite by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Latin America 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Latin America 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Latin America 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: Argentina 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: Argentina 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 217: Argentina 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 220: Brazil 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 223: Brazil 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 226: Brazil 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
MEXICO
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 229: Mexico 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 232: Mexico 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 235: Mexico 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
MIDDLE EAST
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Phosphoramidite by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 247: Middle East 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 253: Middle East 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 256: Middle East 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
IRAN
- TABLE 257: Iran Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 259: Iran 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 262: Iran 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 265: Iran 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 266: Israel Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 268: Israel 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 271: Israel 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 274: Israel 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 284: UAE Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 286: UAE 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 289: UAE 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 292: UAE 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
AFRICA
- Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 302: Africa Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 304: Africa 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 307: Africa 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 310: Africa 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030